Probucol. A reappraisal of its pharmacological properties and therapeutic use in hypercholesterolaemia
作者： Micaela M.-T. Buckley , Karen L. Goa , Allan H. Price , Rex N. Brogden
DOI: 10.2165/00003495-198937060-00002
关键词:
摘要: … diet, and in hyperlipidaemic rabbits, when both groups were fed probucol 0.5 to 1% for up to … seen in Watanabe Heritable Hyperlipidaemic rabbits fed probucol than in those treated with …
springer.com
sci-hub.se 参考文章(104)
Akira Yamamoto, Hitoshi Hara, Shigeko Takaichi, Jun-Ichiro Wakasugi, Munehiro Tomikawa, Effect of probucol on macrophages, leading to regression of xanthomas and atheromatous vascular lesions. American Journal of Cardiology. ,vol. 62, ,(1988) , 10.1016/S0002-9149(88)80048-1
F.N. Marshall, J.E. Lewis, Sensitization to epinephrine-induced ventricular fibrillation produced by probucol in dogs Toxicology and Applied Pharmacology. ,vol. 24, pp. 594- 602 ,(1973) , 10.1016/0041-008X(73)90221-4
Kevin F. Browne, Eric N. Prystowsky, James J. Heger, Benjamin J. Cerimele, Naomi Fineberg, Douglas P. Zipes, Prolongation of the QT interval induced by probucol: Demonstration of a method for determining QT interval change induced by a drug American Heart Journal. ,vol. 107, pp. 680- 684 ,(1984) , 10.1016/0002-8703(84)90315-6
W P Castelli, J T Doyle, T Gordon, C G Hames, M C Hjortland, S B Hulley, A Kagan, W J Zukel, HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. Circulation. ,vol. 55, pp. 767- 772 ,(1977) , 10.1161/01.CIR.55.5.767
R.C. Heel, R.N. Brogden, T.M. Speight, G.S. Avery, Probucol: a review of its pharmacological properties and therapeutic use in patients with hypercholesterolaemia. Drugs. ,vol. 15, pp. 409- 428 ,(1978) , 10.2165/00003495-197815060-00001
C. A. Dujovne, F. Atkins, B. Wong, S. DeCoursey, P. Krehbiel, S. B. Chernoff, Electrocardiographic effects of probucol. A controlled prospective clinical trial European Journal of Clinical Pharmacology. ,vol. 26, pp. 735- 739 ,(1984) , 10.1007/BF00541934
Göran Walldius, Lars A. Carlson, Uno Erikson, Anders G. Olsson, Jan Johansson, Jörgen Mölgaard, Sven Nilsson, Göran Stenport, Lennart Kaijser, Claes Lassvik, Ingar Holme, Development of femoral atherosclerosis in hypercholesterolemic patients during treatment with cholestyramine and probucol/placebo: Probucol quantitative regression Swedish trial (PQRST): A status report American Journal of Cardiology. ,vol. 62, ,(1988) , 10.1016/S0002-9149(88)80049-3
P.N. Durrington, J.P. Miller, Double-blind, placebo-controlled, cross-over trial of probucol in heterozygous familial hypercholesterolaemia Atherosclerosis. ,vol. 55, pp. 187- 194 ,(1985) , 10.1016/0021-9150(85)90097-8
Akira Yamamoto, Yuji Matsuzawa, Bun-ichiro Kishino, Rikuro Hayashi, Kazuhiko Hirobe, Toshiro Kikkawa, Effects of probucol on homozygous cases of familial hypercholesterolemia. Atherosclerosis. ,vol. 48, pp. 157- 166 ,(1983) , 10.1016/0021-9150(83)90102-8
MC Bateson, AM Fiabane, A Clarke, IA Bouchier, Probucol and hypercholesterolaemia. British Journal of Clinical Pharmacology. ,vol. 11, pp. 531- 533 ,(1981) , 10.1111/J.1365-2125.1981.TB01166.X